E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/13/2017 in the Prospect News Preferred Stock Daily.

Preferred stocks subdued as banks start to report quarterly results; Medley sells $25-pars

By Stephanie N. Rotondo

Seattle, Jan. 13 – Bank earnings season kicked off on Friday, with Wells Fargo & Co., Bank of America Corp. and JPMorgan Chase & Co. all reporting fourth-quarter results.

However, the news was doing little to spur activity in the preferred stock space.

“People were expecting good earnings,” a trader said. “BofA is the only one that kind of disappointed. Wells and JPMorgan did well.”

BofA posted earnings per share of 40 cents on revenue of $20.22 billion. EPS was better than analysts’ projections of 38 cents, though revenue was lower than the $20.76 billion forecast.

Though the trader said Wells Fargo outperformed BofA in its earnings report, analysts polled by Thomson Reuters disagreed. The San Francisco-based bank posted EPS of 96 cents, versus estimates of $1.00. Revenue came in at $21.58 billion, compared to expectations of $22.45 billion.

As for JPMorgan, adjusted EPS was $1.58. Analysts polled by Thomson Reuters had predicted EPS of $1.44.

Total revenue was up 2.5% at $24.33 billion, versus forecasts of $23.95 billion.

But while the market had been looking forward to the earnings, there was little reaction in the banks’ preferreds. BofA, for its part, began the day with a mostly weaker tone but managed to end mostly positive.

The 6% series EE noncumulative preferreds (NYSE: BACPrA) declined 7 cents to $25.60, while the 6.625% series W noncumulative preferreds (NYSE: BACPrW) improved 9 cents, closing at $26.30.

Wells Fargo’s preferred issues, however, went the opposite of BofA. They started the day generally higher but eventually closed lower.

The 5.5% series X class A noncumulative preferreds (NYSE: WFCPrX) declined 15 cents to $23.95, as the 5.85% series Q fixed-to-floating rate noncumulative preferreds (NYSE: WFCPrQ) improved 7 cents to $25.80.

In JPMorgan preferreds, the tone was weaker.

The 6.3% series W noncumulative preferreds (NYSE: JPMPrE) fell 13 cents to $26.24. The 6.1% series AA noncumulative preferreds (NYSE: JPMPrG) dipped 4 cents to $26.01.

Medley comes upsized

The primary had a deal enter the market, as Medley LLC priced a $30 million offering of 7.25% $25-par notes due Jan. 30, 2024.

The deal came upsized from $25 million.

A trader saw the paper at $24.75 in early dealings, adding that the paper had already freed to trade.

“FBR did a nice job with that,” he said, referring to the lead bookrunner of the deal.

Along with FBR, Incapital, BB&T Capital Markets, Compass Point, Ladenburg Thalmann & Co. Inc., William Blair and JonesTrading participated in the deal.

There is a $4.5 million over-allotment option, increased from $3.75 million.

Interest is payable on a quarterly basis. The notes become redeemable on or after Jan. 30, 2020 at par plus accrued interest.

Proceeds will be used to repay a portion of outstanding amounts under a senior secured term loan facility with Credit Suisse AG, Cayman Islands Branch.

Medley is a New York-based externally managed, non-diversified closed-end management investment company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.